| SCM | Schwann cell membrane; sensation, circulation, and motion; Society of Computer Medicine; soluble cyt... |
|---|---|
| TCR | T-cell reactivity; T-cell receptor; T-cell rosette; thalamocortical relay; total cytoplasmic ribosom... |
| AMLC | adherent macrophage-like cell; autologous mixed lymphocyte culture |
| MCAR | mixed cell agglutination reaction |
| MCGN | mesangiocapillary glomerulonephritis; minimal change glomerulonephritis; mixed cryoglobulinemia with... |
| diffuse phlegmon | A diffuse inflammation of the subcutaneous tissues accompanied by constitutional symptoms of sepsis. (05 Mar 2000) |
|---|---|
| diffuse pulmonary haemorrhage | <radiology> Thrombocytopenia, coagulopathy, idiopathic pulmonary haemosiderosis, Goodpasture syndrome, systemic lupus erythematosus, Wegeners granulomatosis, polyarteritis nodosa, Henoch-Schonlein purpura, Behcet disease, D-penicillamine, lymphangiography (12 Dec 1998) |
| diffuse waxy spleen | A condition of amyloid degeneration of the spleen, affecting chiefly the extrasinusoidal tissue spaces of the pulp. Synonym: lardaceous spleen (05 Mar 2000) |
| oesophageal spasm, diffuse | A motor disorder of the oesophagus characterised by chest pain and dysphagia. Pathogenesis is unclear. Strong, nonpropulsive contractions of the oesophagus evoked by deglutition occur, especially in the elderly. (12 Dec 1998) |
| keratoderma, palmoplantar, diffuse | An autosomal dominant disorder characterised by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma (keratoderma, palmoplantar), as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present. (12 Dec 1998) |
| leishmaniasis, diffuse cutaneous | A form of leishmaniasis, cutaneous caused by leishmania aethiopica in ethiopia and kenya, l. Pifanoi in venezuela, l. Braziliensis in south america, and l. Mexicana in central america. This disease is characterised by massive dissemination of skin lesions without visceral involvement. (12 Dec 1998) |
| leukodystrophy with diffuse Rosenthal fibre formation | A metabolic disorder whose onset can be in infancy, adolescence, or adulthood; characterised pathologically by widespread cerebral demyelination with astrocyte and primitive oligodendroglial cell proliferation; refractile Rosenthal fibres result from the degeneration of these proliferating cells; aetiology unknown, but possibly due to a metabolic defect of astrocytes; sex-linked recessive disorder. (05 Mar 2000) |
| b and t cell count | A test that measures the respective quantities of B lymphocytes and T lymphocytes. This test is often performed in the analysis of an immune deficiency disorder. Normal values include: 68 to 75% of total lymphocytes are T lymphocytes and 10 to 20% are B lymphocytes. Increased T-cell counts can indicate infectious mononucleosis, acute lymphocytic leukaemia or multiple myeloma. Increased B lymphocytes can indicate chronic lymphocytic leukaemia, multiple myeloma, Waldenstrom's macroglobulinaemia or Di George syndrome. Decreased T-cells may indicate congenital T-cell deficiency, Wiskott-Aldrich syndrome or AIDS. Decreased B-cells may indicate acute lymphocytic leukaemia or a congenital immunoglobulin deficiency disorder. (27 Sep 1997) |
| neoplasms, germ cell and embryonal | Neoplasms composed of primordial germ cells of embryonic gonads or of elements of the germ layers of the embryo. The concept does not refer to neoplasms located in the gonads or present in an embryo or foetus. (12 Dec 1998) |
| nevus, epithelioid and spindle cell | A benign compound nevus occurring most often in children before puberty, composed of spindle and epithelioid cells located mainly in the dermis, sometimes in association with large atypical cells and multinucleate cells, and having a close histopathological resemblance to malignant melanoma. The tumour presents as a smooth to slightly scaly, round to oval, raised, firm papule or nodule, ranging in colour from pink-tan to purplish red, often with surface telangiectasia. (12 Dec 1998) |
| benign lymphoma of the rectum | A rectal polyp composed of lymphoid tissue with follicle formation, covered by mucosa. (05 Mar 2000) |
| burkitt lymphoma | A form of undifferentiated malignant lymphoma usually found in central africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumour in virtually all cases of burkitt lymphoma. The epstein-barr virus (herpes virus 4, human) has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases; however, most non-african cases are ebv-negative. (12 Dec 1998) |
| Burkitt's lymphoma | <oncology, tumour> A type of Non-Hodgkin lymphoma that most often occurs in young people between the ages of 12 and 30. The disease usually causes a rapidly growing tumour in the abdomen. (12 May 1997) |
| cancer, lymphoma, hodgkin's | A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia. (12 Dec 1998) |
| cancer, lymphoma, non-hodgkin's | A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy. (12 Dec 1998) |